Clinical Trial

Fetal Fornix and Hippocampus in Pregnant Women With Early-Onset Preeclampsia

Study acronym: FHC-EOPE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 23, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Since early-onset preeclampsia (EOPE) is commonly associated with inadequate placentation, placental insufficiency, chronic fetal hypoxia, oxidative stress, and heightened inflammation, these pathological processes may adversely affect hippocampal neuronal development and maturation of axonal pathways such as the fornix. These mechanisms support our hypothesis that fetal fornix and hippocampus dimensions may be reduced in pregnancies complicated by EOPE, forming the scientific basis of our study. Previous research has suggested a potential link between preeclampsia (PE) and altered neurocognitive development. However, no studies to date have specifically evaluated the relationship between EOPE and fetal fornix or hippocampus dimensions. Therefore, the objective of our study is to assess fetal fornix and hippocampus measurements in pregnant women with early-onset preeclampsia compared with healthy controls.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-21.
Status change: Not Yet Recruiting → Recruiting 2025-12-21
Trial Details
NCT Number NCT07245056
Lead Sponsor Ankara Etlik City Hospital
Conditions Pre-Eclampsia, Hippocampus
Enrollment 84 participants
Start Date 2025-12-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-23